Cancer cell and T cells

New Directions in Immuno-Oncology: Therapies and stratification

  • Event date: -
  • Start time: 09:00 End time: - 18:00
  • Event Location: The Francis Crick Institute
  • Event Type: Symposia

Following successful first “New Directions in Immuno-Oncology” international conference in 2019, the second conference will focus on Therapies and Stratification in September 2021. Our intention is to bring together a broad cross-section of the community of researchers and clinicians working at the cutting edge of immuno-oncology interventions and their stratified application. The conference will cover both the immediate and longer-term prospects in the development pipeline and the means through which we might better determine effective deployment of these interventions.

Registration and abstract submission will open later in 2020.

Registration fees cover the conference on Monday 06 September and Tuesday 07 September. Workshops places are limited to 25 per workshop and attendance can be purchased additionally during checkout.

The final programme and list of speakers will be announced soon. 

Provisional programme

Confirmed speakers

Sandra Demaria

Sandra Demaria

Weill Cornell Medical College
New York, USA

Charles Drake

Charles G. Drake

Columbia University
New York, USA

John Haanen

John Haanen

Netherlands Cancer Institute
Amsterdam, Netherlands

Tim Illidge

Tim Illidge

University of Manchester
Manchester, UK

Jonathan Irish

Jonathan Irish

Vanderbilt School of Medicine
Nashville, USA

Claudia Kemper

Claudia Kemper

National Institutes of Health
Bethesda, USA

Gary Middleton

Gary Middleton

University of Birmingham
Birmingham, UK

Michele Mishto

Michele Mishto

King's College London
London, UK

Johanna olweus

Johanna Olweus

Oslo University Hospital
Oslo, Norway

Lucia Possamai

Lucia Possamai

Imperial College London
London, UK

Martin Pule

Martin Pule

University College London
London, UK

Kurt Schalper

Kurt Schalper

Yale School of Medicine
New Haven, USA

Ralph R. Weichselbaum

Ralph Weichselbaum

University of Chicago Medical Center
Chicago, USA

Roberta Zappasodi

Roberta Zappasodi

Memorial Sloan Kettering
New York, USA

Conference organisers

Fran Balkwill

Fran Balkwill

Queen Mary University
London, UK

Francesca Ciccarelli

Francesca Ciccarelli

The Francis Crick Institute
London, UK

Adrian Hayday

Adrian Hayday

The Francis Crick Institute
London, UK

Crispin Hiley

Crispin Hiley

University College London
London, UK

Jonathan Irish

Jonathan Irish

Vanderbilt School of Medicine
Nashville, USA

Shahram Kordasti

Shahram Kordasti

King's College London
London, UK

Peter Parker

Peter Parker

The Francis Crick Institute
London, UK

Thomas Powles

Thomas Powles

Cancer Research UK Barts Centre
London, UK

Sergio Quezada

Sergio Quezada

University College London
London, UK

James Spicer

James Spicer

Kings College London
London, UK

Karin Straathof

Karin Straathof

University College London
London, UK

Samra Turajlic

Samra Turajlic

The Francis Crick Institute
London, UK

Ben Willcox

Ben Willcox

University of Birmingham
Birmingham, UK

Sponsors

Gold sponsor

Beckman Coulter

Beckman Coulter Life Sciences is dedicated to developing and providing advanced technologies and equipment for research and discovery to explore new treatment methods. Our products are implemented in all major areas of Life Sciences to simplify and automate existing processes in the lab.

For more information please visit www.beckman.com

Gold sponsor

Fluidigm

Fluidigm is committed to empowering the cancer immunotherapy community with research tools to interrogate immune cell function and the tumor microenvironment with unprecedented resolution. Using proven mass cytometry and microfluidic technologies, we provide workflows to identify and characterize changes in cellular phenotypes at single-cell resolution. Engage with us a fluidigm.com

Sponsor Information

To find out more about our sponsorship opportunities please download our sponsor information pack.